WNK2 and melanoma: The activation of the same molecular pathways involved in canine and human melanoma progression, such as alterations in the Mitogen-Activated Protein Kinase (MAPK) and phosphatidyl-inositol 3-kinase/serine-threonine kinase (PI3K/AKT) pathways, show remarkable similarity across species.